the management of osteoarthritis represents a real challengethis complex and multifactorial disease evolves over decades and requires not only the alleviation of symptoms iepain and joint function but also the preservation of articular structure without side effectsnutraceuticals are good candidates for the management of oa due to their safety profile and potential efficacyhowever they are not part of the treatment guidelines and published recommendationscurcumin is the yellow pigment isolated from the rhizomes of curcuma longa commonly known as turmericcurcumin is a highly pleiotropic molecule with an excellent safety profilestrong molecular evidence has been published for its potency to target multiple inflammatory diseaseshowever naturally occurring curcumin cannot achieve its optimum therapeutic outcomes due to its low solubility and poor bioavailabilitynevertheless curcumin presents great potential for treating oa and has been categorized as having preclinical evidence of efficacythis review aimed at gathering most of the available information to document the potential efficacy of curcumin based on the results obtained in in vitro models of cartilage and osteoarthritis and in other diseases